Litcius/Paper detail

Stability-indicating HPLC-DAD method for the determination of empagliflozin

Shilpi Pathak, Pradeep Mishra

2021Future Journal of Pharmaceutical Sciences11 citationsDOIOpen Access PDF

Abstract

Abstract Background A stability-indicating RP-HPLC method was developed and validated for the estimation of empagliflozin drug and its tablet dosage form using a DAD detector. The mobile phase consisted of methanol/acetonitrile/0.1%OPA (75:20:5). The peak was observed at 2.54 min using 222.0 nm absorption maxima. Results Calibration curve plot was found within the range of 10–50 µg/mL. The coefficient of determination ( R 2 ) was found to be 0.9990. Forced degradation studies were performed for the empagliflozin in various conditions, and the results were calculated as %RSD values and were found to be within the limits. Conclusion The method was validated as per ICH guidelines with respect to all validation parameters.

Topics & Concepts

EmpagliflozinChromatographyCalibration curveChemistryHigh-performance liquid chromatographyMethanolAnalytical Chemistry (journal)Detection limitMedicineDiabetes mellitusType 2 Diabetes MellitusEndocrinologyOrganic chemistryDiabetes Treatment and ManagementAnalytical Methods in PharmaceuticalsDiabetes Management and Research
Stability-indicating HPLC-DAD method for the determination of empagliflozin | Litcius